Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Ascentage, Biontech, Incannex Healthcare, Janssen-Cilag, LG Chem Life Sciences, Mesoblast, Moderna, Neuren, Pfizer, Regent Pacific, Rhizen, Shanghai Junshi, Telix, Transthera, Wanbang, Yiling.